Zealand Pharma A/S | ZEAL - Interest Expense On Debt

Stock Price
291.70
Daily Change
-2.30 -0.78%
Monthly
-20.58%
Yearly
-37.38%
Q1 Forecast
273.20

Zealand Pharma A/S reported 7.07M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Akebia Therapeutics 4.83M 359.32M Dec/2025
Alaunos Therapeutics USD 1.07M 215K Jun/2023
Avita Medical AUD 1.25M 100K Jun/2025
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Ionis Pharmaceuticals USD 18M 0 Dec/2025
IQVIA Holdings USD 193M 4M Dec/2025
Moderna USD 12.14B 12.13B Sep/2025
Organon & Co USD 128M 3M Sep/2025
Revvity USD 23.51M 742K Dec/2025
Tectonic Therapeutic USD 12K 276.99M Dec/2025
Tilray USD 6.7M 2.73M Jun/2025
Viatris USD 119.6M 0 Dec/2025
Xeris Pharmaceuticals USD 7.15M 115K Dec/2025
Zealand Pharma A/S 7.07M 74K Dec/2025